Delisting riskPopularity #4,280
Artelo Biosciences (ARTL)
Develops cannabinoid and fatty-acid-binding-protein drug candidates for cancer supportive care and pain.
$4.23
After hours+0.06 (+1.41%)
At close$4.18(+1.83%)
Something off on this page? Send us feedback.
Next report
Nov 17, 26
estimated · in 56 days
EPS estimate
−$7.02
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported−$21.06−$12.96−$16.83−$11.91−$6.66−$4.00−$8.01Pending
Estimate−$6.66−$2.40−$12.57−$2.46−$4.71−$0.78−$6.48−$7.02
Surprise−216.2%−440.1%−33.9%−384.1%−41.4%−412.8%−23.6%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported———————Pending
Estimate————————
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | −$4.41 | — | — |
| Sep 2028 | −$3.97 | — | — |
| Jun 2028 | −$3.69 | — | — |
| Mar 2028 | −$3.89 | — | — |
| Dec 2027 | −$4.31 | — | — |
| Sep 2027 | −$3.89 | — | — |
| Jun 2027 | −$3.61 | — | — |
| Mar 2027 | −$3.81 | — | — |
| Dec 2026 | −$7.83 | — | — |
| Nov 2026 | −$7.02 | — | — |
| Aug 2026 | −$6.48 | −$8.01 | −23.6% |
| May 2026 | −$0.78 | −$4.00 | −412.8% |
| Feb 2026 | −$4.71 | −$6.66 | −41.4% |
| Nov 2025 | −$2.46 | −$11.91 | −384.1% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Apr 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Jan 2022 | |||
| Nov 2021 | |||
| Jul 2021 | |||
| Apr 2021 | |||
| Jan 2021 | |||
| Nov 2020 | |||
| Jul 2020 | |||
| Apr 2020 | |||
| Jan 2020 | |||
| Nov 2019 | |||
| Jul 2019 | |||
| Apr 2019 | |||
| Jan 2019 | |||
| Nov 2018 | |||
| Jul 2018 | |||
| Apr 2018 | |||
| Jan 2018 | |||
| Nov 2017 | |||
| Jul 2017 | |||
| Apr 2017 | |||
| Jan 2017 | |||
| Nov 2016 | |||
| Jul 2016 | |||
| Apr 2016 | |||
| Jan 2016 | |||
| Dec 2015 | |||
| Jul 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | −$4.41 | — | — | $0 | — | — | — |
| Sep 2028 | −$3.97 | — | — | $0 | — | — | — |
| Jun 2028 | −$3.69 | — | — | $0 | — | — | — |
| Mar 2028 | −$3.89 | — | — | $0 | — | — | — |
| Dec 2027 | −$4.31 | — | — | $0 | — | — | — |
| Sep 2027 | −$3.89 | — | — | $0 | — | — | — |
| Jun 2027 | −$3.61 | — | — | $0 | — | — | — |
| Mar 2027 | −$3.81 | — | — | $0 | — | — | — |
| Dec 2026 | −$7.83 | — | — | $0 | — | — | — |
| Nov 17, 2026 | −$7.02 | — | — | $0 | — | — | — |
| Aug 12, 2026 | −$6.48 | −$8.01 | −23.6% | — | — | — | −1.5% |
| May 14, 2026 | −$0.78 | −$4.00 | −412.8% | — | — | — | +1.3% |
| Feb 24, 2026 | −$4.71 | −$6.66 | −41.4% | — | — | — | +4.8% |
| Nov 12, 2025 | −$2.46 | −$11.91 | −384.1% | — | — | — | −8.2% |
| Aug 12, 2025 | |||||||
| May 13, 2025 | |||||||
| Mar 24, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 13, 2024 | |||||||
| May 13, 2024 | |||||||
| Mar 29, 2024 | |||||||
| Nov 13, 2023 | |||||||
| Aug 10, 2023 | |||||||
| May 11, 2023 | |||||||
| Apr 17, 2023 | |||||||
| Nov 8, 2022 | |||||||
| Aug 9, 2022 | |||||||
| May 12, 2022 | |||||||
| Jan 12, 2022 | |||||||
| Nov 29, 2021 | |||||||
| Jul 12, 2021 | |||||||
| Apr 13, 2021 | |||||||
| Jan 14, 2021 | |||||||
| Nov 4, 2020 | |||||||
| Jul 13, 2020 | |||||||
| Apr 14, 2020 | |||||||
| Jan 14, 2020 | |||||||
| Nov 25, 2019 | |||||||
| Jul 15, 2019 | |||||||
| Apr 15, 2019 | |||||||
| Jan 14, 2019 | |||||||
| Nov 29, 2018 | |||||||
| Jul 13, 2018 | |||||||
| Apr 16, 2018 | |||||||
| Jan 16, 2018 | |||||||
| Nov 29, 2017 | |||||||
| Jul 21, 2017 | |||||||
| Apr 14, 2017 | |||||||
| Jan 10, 2017 | |||||||
| Nov 29, 2016 | |||||||
| Jul 5, 2016 | |||||||
| Apr 1, 2016 | |||||||
| Jan 14, 2016 | |||||||
| Dec 11, 2015 | |||||||
| Jul 15, 2015 |